Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin for Bladder Dysfunction in MS
NCT00688948Phase 3Terminated
- Sponsor
- Nova Scotia Health
- Start
- Nov 2007
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alfuzosin in Bladder dysfunction, sponsored by Nova Scotia Health. Started Nov 2007; status: terminated.
02
Drugs
alfuzosin
03
Conditions
Bladder dysfunction
Beyond the preview
Go deeper on NCT00688948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00688948.